Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/ no-reflow during angioplasty: A clinical scenario of ischemic preconditioning

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 3-4, 2007, Pages 476-482

  Parikh, Keyur H ^a   Chag, Milan C ^a   Shah, Kanan J ^b   Shah, Urmil G ^a   Baxi, Hemang A ^a   Chandarana, Anish H ^a   Naik, Ajay M ^a   Shah, Joyal N ^a   Shah, Hetal D ^a,b   Goyal, Ramesh K ^b  

^a The Heart Care Clinic   (India)

^b L M COLLEGE OF PHARMACY   (India)

Author keywords

Adenosine; Intracoronary; No reflow; Percutaneous coronary intervention; Sodium nitroprusside

Indexed keywords

ADENOSINE; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE;

ACUTE CORONARY SYNDROME; ARTICLE; BLOOD CLOT LYSIS; BOLUS INJECTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; ADENOSINE; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY CIRCULATION; CORONARY DISEASE; DRUG ADMINISTRATION ROUTES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; NITRIC OXIDE DONORS; NITROPRUSSIDE; VASODILATOR AGENTS;

EID: 34547888759     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-013     Document Type: Article

References (44)

1. Abbo, K.M., Dooris, M., Glazier, S., O'Neill, W.W., Byrd, D., Grines, C.L., and Saan, R.D. 1995. Features and outcome of no-reflow after percutaneous coronary intervention. Am. J. Cardiol. 75: 778-782. doi:10.1016/S0002- 9149(99)80410-X. PMID:7717278.
2. Akasaka, T., Yoshida, K., Kawamoto, T., Kaji, S., Ueda, Y., Yamamuro, A., Takagi, T., and Hozumi, T. 2000. Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. Circulation, 101: 2361-2367. PMID:10821811.
3. Barcin, C., Denktas, A.E., Lennon, R.J., Lavon, H., Higano, S.T., Holms, D.R., Garrat, K.N., and Lerman, A. 2004. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon. Catheter. Cardiovasc. Interv. 61: 484-491. PMID: 15065143.
4. Bates, J.N., Baker, M.T., Guerra, R., Jr., and Harrison, D.G. 1991. Nitric oxide generation from nitroprusside by vascular tissue-evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem. Pharmacol. 42: S157-S165. doi:10. 1016/0006-2952(91)90406-U. PMID:1768273.
5. Carden, D.L., and Granger, D.N. 2000. Pathophysiology of ischemia reperfusion injury. J. Pathol. 190: 255-266. doi:10.1002/ (SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6. PMID:10685060.
6. Chilian, W.M., Dellsperger, K.C., Layne, S.M., Eastham, C.L., Armstrong, M.A., Marcus, M.L., and Heistad, D.D. 1990. Effects of atherosclerosis on the coronary microcirculation. Am. J. Physiol. 258: H529-H539. PMID:2309917.
7. Duilio, C., Ambrosio, G., Kuppusamy, P., DiPaula, A., Becker, L.C., and Zweier, J.L. 2001. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am. J. Physiol. Heart Circ. Physiol. 280: H2649-H2657. PMID:11356621.
8. Eeckhout, E., and Kern, M.J. 2001. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur. Heart J. 22: 729-739. doi:10.1053/euhj.2000.2172. PMID:11350105.
9. Erbel, R., and Heusch, G. 2000. Coronary microembolization. J. Am. Coll. Cardiol. 36: 22-24. doi:10.1016/S0735-1097(00) 00708-7. PMID:10898407.
10. Fischell, T.A., Carter, A.J., Foster, M.T., Hempsall, K., DeVries, J., Kim, D.H., and Kloostra, A. 1998. Reversal of "no reflow" during vein graft stenting using high velocity boluses of intracoronary adenosine. Cathet. Cardiovasc. Diagn. 45: 360-365. doi:10. 1002/(SICI) 1097-0304( 199812)45:4<360::AID-CCD1>3.0.CO;2-R. PMID:9863736.
11. Fugit, M.D., Rubal, B.J., and Donovan, D.J. 2000. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow. J. Invasive Cardiol. 12: 80-85. PMID:10731269.
12. Glyn, M.C., and Ward, B.J. 2000. Contraction in cardiac endothelial cells contributes to changes in capillary dimensions following ischaemia and reperfusion. Cardiovasc. Res. 48: 346-356. doi:10.1016/S0008-6363(00) 00173-5. PMID:11054480.
13. Hein, T.W., and Kuo, L. 1999. cAMP-independent dilation of coronary arterioles to adenosine: role of nitric oxide, G proteins, and K(ATP) channels. Circ. Res. 85: 634-642. PMID:10506488.
14. Ikeda, N., Yasu, T., and Kubo, N. 2004. Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction. Heart, 90: 181-185. doi:10.1136/hrt.2003.013789. PMID:14729792.
15. Ito, H., Maruyama, A., Iwakura, K., Masuyama, T., Hori, M., Takiuchi, S., et al. 1996. Clinical implications of "no-reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation, 93: 223-228. PMID:8548892.
16. Iwakura, K., Ito, H., Takiuchi, S., Taniyama, Y., Nakatsuchi, Y., Negoro, S., et al. 1996. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation, 94: 1269-1275. PMID: 8822979.
17. Kaplan, B.M., Benzuly, K.H., Kinn, J.W., Bowers, T.R., Tilli, F.V., Grines, C.L., O'Neill, W.W., and Safian, R.D. 1996. Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet. Cardiovasc. Diagn. 39: 113-118. doi:10.1002/(SICI)1097-0304(199610) 39:2<113::AID-CCD1>3.0.CO;2-I. PMID:8922307.
18. Kawamoto, T., Yoshida, K., Akasaka, T., Hozumi, T., Takagi, T., Kaji, S., and Ueda, Y. 1999. Can coronary blood flow velocity pattern after primary percutaneous transluminal coronary angioplasty predicts recovery of regional left ventricular function in patients with acute myocardial infarction? Circulation, 100: 339-345. PMID:10421592.
19. Kemp, B.K., and Cocks, T.M. 1999. Adenosine mediates relaxation of human small resistance-like coronary arteries via A2B receptors. Br. J. Pharmacol. 126: 1796-1800. doi:10.1038/sj.bjp. 0702462. PMID:10372822.
20. Kern, M.J., Moore, J.A., Aguiurre, F.V., Bach, R.G., Caracciolo, E.A., Wolford, T., et al. 1996. determination of angiographic (TIMI grade) blood flow by intracoronary Doppler flow velocity during acute myocardial infarction. Circulation, 94: 1545-1552. PMID:8840842.
21. Kloner, R.A. 1989. No reflow revisited. J. Am. Coll. Cardiol. 14: 1814-1815. PMID:2584573.
22. Kloner, R.A., Ganote, C.E., and Jennings, R.B. 1974. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J. Clin. Invest. 54: 1496-1508. PMID:4140198.
23. Kondo, M., Nakano, A., Saito, D., and Shimono, Y. 1998. Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 32: 898-903. doi:10.1016/80735-1097(98) 00435-5. PMID:9768709.
24. Kuo, L., Chilian, W., and Davis, M. 1991. Interaction of pressure-induced and flow-induced responses in porcine coronary resistance vessels. Am. J. Physiol. 261: H1706-H1715. PMID: 1750529.
25. Kurz, M.A., Lamping, K.G., Bates, J.N., Eastham, C.L., Marcus, M.L., and Harrison, D.G. 1991. Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin. Circ. Res. 68: 847-855. PMID:1742870.
26. Laude, K., Beauchamp, P., Thuillez, C., and Richard, V. 2002. Endothelial protective effects of preconditioning. Cardiovasc. Res. 55: 466-473. doi:10.1016/S0008-6363(02)00277-8. PMID:12160943.
27. Leopold, J.A., Berger, J.C., Cuppels, L.A., Berg, J.D., and Jacobs, A.K. 2000. Noreflow during coronary intervention: observations and implications. Circulation, 102(Suppl. 2): 644.
28. Lloyd-Jones, D.M., and Bloch, K.D. 1996. The vascular biology of nitric oxide and its role in atherogenesis. Annu. Rev. Med. 47: 365-375. doi:10.1146/annurev.med.47.1.365. PMID:8712788.
29. Loukogeorgakis, S.P., Panagiotidou, A.T., Broadhead, M.W., Donald, A., Deanfield, J.E., and MacAllister, R.J. 2005. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. J. Am. Coll. Cardiol. 46: 450-456. doi:10.1016/j.jacc.2005.04.044. PMID:16053957.
30. Ma, X.L., Tsao, P.S., and Viehman, G.E. 1991. Lefer AM. Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion- reperfused cat coronary artery. Circ. Res. 69: 95-106. PMID:2054945.
31. Morishima, I., Sone, T., Mokuno, S., Tsuboi, H., Kondo, J., Mukawa, H., et al. 1995. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am. Heart J. 130: 239-243. doi:10.1016/ 0002-8703(95)90434-4. PMID:7631601.
32. Murohara, T., Buerke, M., and Lefer, A.M. 1994. Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction: role of selectins. Arterioscler. Thromb. 14: 1509-1519. PMID:7520747.
33. Myers, P.R., Banit, P.F., Guerra, R., Jr., and Harrison, D.G. 1989. Characteristics of canine coronary resistance arteries: importance of the endothelium. Am. J. Physiol. 257: H603-H610. PMID:2788367.
34. Opie, L.H. 1992. Cardiac metabolism-Emergence, decline and resurgence. Part II. Cardiovasc. Res. 26: 817-830. PMID:1451158.
35. Piana, R.N., Paik, G.Y., Moscucci, M., Cohen, D.J., Gibson, C.M., Kugelmass, A.D., et al. 1994. Incidence and treatment of no-reflow after percutaneous coronary intervention. Circulation, 89: 2514-2518. PMID:8205658.
36. Przyklenk, K., Darling, C.E., Dickson, E.W., and Whittaker, P. 2003. Cardioprotection outside the box - the evolving paradigm of remote preconditioning. Basic Res. Cardiol. 98: 149-157. PMID:12883832.
37. Radomski, M.W., and Moncada, S. 1993. Regulation of vascular hemostasis by nitric oxide. Thromb. Haemost. 70: 36-41. PMID:7694388.
38. Rawitscher, D., Levin, T.N., Cohen, I., and Feldman, T. 1997. Rapid reversal of no-reflow using abciximab after coronary device intervention. Cathet. Cardiovasc. Diagn. 42: 187-190. doi:10. 1002/(SICI)1097- 0304(199710)42:2<187::AID-CCD20>3.0. CO;2-K. PMID:9328705.
39. Resnic, F.S., Wainstein, M., Lee, M.K., Behrendt, D., Wainstein, R.V., Ohno-Machado, L., et al. 2003. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am. Heart J. 145: 42-46. doi:10. 1067/mhj.2003.36. PMID:12514653.
40. Sellke, F.W., Armstrong, M.L., and Harrison, D.G. 1990. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation, 81: 1586-1593. PMID:2110036.
41. Tanner, F.C., Boulanger, C.M., and Luscher, T.F. 1993. Endothelium-derived nitric oxide, endothelin and platelet vessel wall interaction: alterations in hypercholesterolemia and atherosclerosis. Semin. Thromb. Hemost. 19: 167-175. PMID:8356462.
42. Traverse, J.H., Kinn, J.W., Klassen, C., Duncker, D.J., and Bache, R.J. 1998. Nitric oxide inhibition impairs blood flow during exercise in hearts with a collateral dependent myocardial region. J. Am. Coll. Cardiol. 31: 67-74. doi:10.1016/S0735-1097(97) 00437-3. PMID:9426020.
43. Wainstein, M., Resnic, F.S., Lee, M.K.Y., Kirshenbaum, J.M., Popma, J.J., Ohro-Machado, L., et al. 2001. Lack of clinical efficacy of pharmacologic treatment of the no-reflow phenomenon despite significant angiographic improvement. J. Am. Coll. Cardiol. 37: 83A.
44. Wilson, R.F., Laxson, D.D., Lesser, J.R., and White, C.W. 1989. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet, 1: 807-811. PMID:2564903.